Neutropenia after the coadministration of clozapine and nirmatrelvir-ritonavir in a patient with SARS-CoV-2 infection: A case report with a literature review

BACKGROUND: Schizophrenia is considered one of the major risk factors for mortality from SARS-CoV-2 infection. Early antiviral treatment is important to decrease the risk of mortality. Currently, Paxlovid (nirmatrelvir-ritonavir) has been widely used in SARS-CoV-2 patients with risk factors. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chun-I, Goh, Kah Kheng, Chen, Chun-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810620/
https://www.ncbi.nlm.nih.gov/pubmed/36620672
http://dx.doi.org/10.3389/fpsyt.2022.1096006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810620/
https://www.ncbi.nlm.nih.gov/pubmed/36620672
http://dx.doi.org/10.3389/fpsyt.2022.1096006

Ejemplares similares